# ClinicalTrials.gov record NCT03298087

> PeptideScanner retained ClinicalTrials.gov record NCT03298087 at 2026-07-30T18:23:09.823Z. Its registry update date was 2025-08-01, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct03298087-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-08-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03298087-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03298087-leuprolide-v1.json
- Content SHA-256: `e4f125d4535f683200b03e50481b595febd9db5f1ea890a4ca87092277f44ffa`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03298087 ([`ctg-observation-nct03298087-2025-08-01-1e574250deb9`](#source-ctg-observation-nct03298087-2025-08-01-1e574250deb9))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03298087 at 2026-07-30T18:23:09.823Z. Its registry update date was 2025-08-01, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct03298087-2025-08-01-1e574250deb9`](#source-ctg-observation-nct03298087-2025-08-01-1e574250deb9))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03298087 at 2026-07-30T18:23:09.823Z. Its registry update date was 2025-08-01, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct03298087-2025-08-01-1e574250deb9`](#source-ctg-observation-nct03298087-2025-08-01-1e574250deb9))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03298087-2025-08-01-1e574250deb9`](#source-ctg-observation-nct03298087-2025-08-01-1e574250deb9))

## Sources

<a id="source-ctg-observation-nct03298087-2025-08-01-1e574250deb9"></a>
- **ClinicalTrials.gov record NCT03298087 · retained source version 2025-08-01:1e574250deb9f71b245a382cae2b22737738a65f97de6f002790051ec6e7b403** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03298087) (`ctg-observation-nct03298087-2025-08-01-1e574250deb9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03298087." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03298087-leuprolide-v1.json SHA-256: e4f125d4535f683200b03e50481b595febd9db5f1ea890a4ca87092277f44ffa.